Immune complex (IC) vaccines have been successfully used to increase immune responses against various pathogens, including HIV-1. Additionally, IC vaccines can induce qualitatively different antibody responses, with distinct antigenic specificities compared to the same antigens used alone. Here we measured the HIV-1-specific antibody responses in female New Zealand White rabbits after immunization with ICs made from BG505 SOSIP.664 trimers (BG505 trimers) and three rabbit monoclonal antibodies (MAbs) with different neutralization profiles. Two of the MAbs were specific for a hole in the glycan shield of the BG505 trimer, while the third, which bound less avidly, was specific for determinants at the gp41-gp120 interface. We found that immuni...
Summary Recent efforts toward HIV vaccine development include the design of immunogens that can enga...
Recent efforts toward HIV vaccine development include the design of immunogens that can engage B cel...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers ...
The high viral diversity of HIV-1 is a formidable hurdle for the development of an HIV-1 vaccine. El...
Recombinant soluble HIV-1 envelope glycoprotein (Env) SOSIP trimers are a design platform for induci...
Since its discovery in 1981, HIV-1 has infected almost 78 million people, and ~39 million people hav...
AbstractThe elicitation of broadly neutralizing antibodies directed against the human immunodeficien...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
<div><p>The native-like, soluble SOSIP.664 trimer based on the BG505 clade A <i>env</i> gene of HIV-...
IntroductionNeutralizing antibodies (Abs) are one of the immune components required to protect again...
AbstractImproving the potency, breadth, and durability of neutralizing antibody responses to HIV are...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
Summary Recent efforts toward HIV vaccine development include the design of immunogens that can enga...
Recent efforts toward HIV vaccine development include the design of immunogens that can engage B cel...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
To date, immunization studies of rabbits with the BG505 SOSIP.664 HIV envelope glycoprotein trimers ...
The high viral diversity of HIV-1 is a formidable hurdle for the development of an HIV-1 vaccine. El...
Recombinant soluble HIV-1 envelope glycoprotein (Env) SOSIP trimers are a design platform for induci...
Since its discovery in 1981, HIV-1 has infected almost 78 million people, and ~39 million people hav...
AbstractThe elicitation of broadly neutralizing antibodies directed against the human immunodeficien...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
In HIV-1 vaccine research, native-like, soluble envelope glycoprotein SOSIP trimers are widely used ...
<div><p>The native-like, soluble SOSIP.664 trimer based on the BG505 clade A <i>env</i> gene of HIV-...
IntroductionNeutralizing antibodies (Abs) are one of the immune components required to protect again...
AbstractImproving the potency, breadth, and durability of neutralizing antibody responses to HIV are...
The native-like, soluble SOSIP.664 trimer based on the BG505 clade A env gene of HIV-1 is immunogeni...
Summary Recent efforts toward HIV vaccine development include the design of immunogens that can enga...
Recent efforts toward HIV vaccine development include the design of immunogens that can engage B cel...
A major advance in the search for an HIV vaccine has been the development of a near-native Envelope ...